Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $2.9100 (-3.32%) ($2.9100 - $2.9100) on Fri. Mar. 4, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.87% (three month average) | RSI | 44 | Latest Price | $2.9100(-3.32%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -0.7% a day on average for past five trading days. | Weekly Trend | CGEN advances 0.4% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XBI(86%) IWO(84%) SKYY(84%) QQQ(83%) ARKG(81%) | Factors Impacting CGEN price | CGEN will decline at least -1.935% in a week (0% probabilities). VIXM(-80%) VXX(-59%) UUP(-31%) EDOC(-27%) TBT(-11%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.935% (StdDev 3.87%) | Hourly BBV | -1.3 () | Intraday Trend | 0% | | | |
|
Resistance Level | $3.05 | 5 Day Moving Average | $3.07(-5.21%) | 10 Day Moving Average | $2.98(-2.35%) | 20 Day Moving Average | $3.05(-4.59%) | To recent high | -38.2% | To recent low | 5.8% | Market Cap | $241m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |